Abstract
Background: Early detection and timely prophylaxis can retard the progression of osteoporosis. The purpose of this study was to determine the usefulness of peripheral Dual Energy X-ray Absorptiometry(DXA) for osteoporosis screening. We utilized AKDX-09W-I, a domestic brand instrument to perform peripheral DXA. Briefly, we acquired bone mineral density (BMD) data from manufacturer-supplied density-gradient phantoms and 30 volunteers to investigate its accuracy and precision, then we measured BMD from 150 volunteers using both AKDX (left forearm) and Hologic Discovery Wi (left forearm, left hip and L1 - L4 vertebrae) simultaneously. Correlation analysis of BMD results from two instruments was assessed by simple linear regression, the Receiver Operating Characteristic (ROC) curves and Areas Under the Curves (AUCs) were evaluated for the diagnostic value of left forearm BMD from AKDX in detecting osteoporosis.Results: In vitro precision errors of AKDX BMD were 0.40%, 0.20%, 0.19%, respectively, on low-, medium-, and high-density phantom; in vivo precision was 1.65%. Positive correlation was observed between AKDX BMD and Hologic BMD at the forearm (r = 0.670), L1–L4 (r = 0.430, femoral neck (r = 0.449), and total hip (r = 0.559). With Hologic DXA T-score as the gold standard, the sensitivity of AKDX T-score < -1 for identifying suboptimal bone health was 63.0% and 76.1%, respectively, at the distal one-third radius and at any site, and the specificity was 73.9% and 90.0%, respectively; the AUCs were 0.708 and 0.879. The sensitivity of AKDX T-score ≤ -2.5 for identifying osteoporosis at the distal one-third radius and at any site was 76.9% and70.4%, respectively, and the specificity was 80.4% and 78.0%, respectively; the AUCs were 0.823 and 0.778.Conclusions: Peripheral DXA appears to be a reliable tool for prescreening for osteoporosis.